132 related articles for article (PubMed ID: 38308843)
1. Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD
Kinsolving J; Bous J; Kozielewicz P; Košenina S; Shekhani R; Grätz L; Masuyer G; Wang Y; Stenmark P; Dong M; Schulte G
Cell Rep; 2024 Feb; 43(2):113727. PubMed ID: 38308843
[TBL] [Abstract][Full Text] [Related]
2. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition of frizzled proteins by
Chen P; Tao L; Wang T; Zhang J; He A; Lam KH; Liu Z; He X; Perry K; Dong M; Jin R
Science; 2018 May; 360(6389):664-669. PubMed ID: 29748286
[No Abstract] [Full Text] [Related]
4. Pro-Inflammatory Cytokines Enhanced In Vitro Cytotoxic Activity of
Fettucciari K; Spaterna A; Marconi P; Bassotti G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256032
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding mechanisms of Clostridioides difficile toxin B and implications for therapeutics development.
Chen P; Jin R
FEBS J; 2023 Feb; 290(4):962-969. PubMed ID: 34862749
[TBL] [Abstract][Full Text] [Related]
6. Structural dynamics of receptor recognition and pH-induced dissociation of full-length Clostridioides difficile Toxin B.
Jiang M; Shin J; Simeon R; Chang JY; Meng R; Wang Y; Shinde O; Li P; Chen Z; Zhang J
PLoS Biol; 2022 Mar; 20(3):e3001589. PubMed ID: 35324891
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B.
Guo S; Chen Y; Liu J; Zhang X; Liu Z; Zhou Z; Wei W
Sci China Life Sci; 2022 Jan; 65(1):107-118. PubMed ID: 34279819
[TBL] [Abstract][Full Text] [Related]
8. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.
Tao L; Zhang J; Meraner P; Tovaglieri A; Wu X; Gerhard R; Zhang X; Stallcup WB; Miao J; He X; Hurdle JG; Breault DT; Brass AL; Dong M
Nature; 2016 Oct; 538(7625):350-355. PubMed ID: 27680706
[TBL] [Abstract][Full Text] [Related]
9. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
[TBL] [Abstract][Full Text] [Related]
10. TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile.
Luo J; Yang Q; Zhang X; Zhang Y; Wan L; Zhan X; Zhou Y; He L; Li D; Jin D; Zhen Y; Huang J; Li Y; Tao L
Cell; 2022 Mar; 185(6):980-994.e15. PubMed ID: 35303428
[TBL] [Abstract][Full Text] [Related]
11. Expression and (Lacking) Internalization of the Cell Surface Receptors of
Schöttelndreier D; Seeger K; Grassl GA; Winny MR; Lindner R; Genth H
Front Microbiol; 2018; 9():1483. PubMed ID: 30022975
[TBL] [Abstract][Full Text] [Related]
12. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of bezlotoxumab binding specificity to toxin B in
Karnchanapandh K; Hanpaibool C; Sanachai K; Rungrotmongkol T
J Biomol Struct Dyn; 2024; 42(4):1617-1628. PubMed ID: 37098802
[No Abstract] [Full Text] [Related]
14. Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection.
Chen P; Zeng J; Liu Z; Thaker H; Wang S; Tian S; Zhang J; Tao L; Gutierrez CB; Xing L; Gerhard R; Huang L; Dong M; Jin R
Nat Commun; 2021 Jun; 12(1):3748. PubMed ID: 34145250
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
[TBL] [Abstract][Full Text] [Related]
16. Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027.
Peng Z; Simeon R; Mitchell SB; Zhang J; Feng H; Chen Z
mSphere; 2019 Oct; 4(5):. PubMed ID: 31578248
[No Abstract] [Full Text] [Related]
17. Cytotoxic synergism of
Bassotti G; Fruganti A; Stracci F; Marconi P; Fettucciari K
World J Gastroenterol; 2023 Jan; 29(4):582-596. PubMed ID: 36742168
[No Abstract] [Full Text] [Related]
18. Receptor Binding Domains of TcdB from
Henkel D; Tatge H; Schöttelndreier D; Tao L; Dong M; Gerhard R
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255261
[TBL] [Abstract][Full Text] [Related]
19. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
20. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
